Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Kettenmann, Helmut Prof. Dr. (1) Kieback, Elisa Dr. (2) Leisegang, Matthias Dr. (5) Lorenz, Felix Dr. (2) Poncette, Lucia (1) Uckert, Wolfgang Prof. Dr. (12) (-) Blankenstein, Thomas Prof. Dr. (4) 1998 (2) 2000 (2) 2004 (1) 2005 (3) 2006 (2) 2007 (1) 2008 (1) (-) 2010 (1) (-) 2011 (2) 2014 (1) 2015 (2) 2016 (1) 2017 (1) (-) 2019 (1) Bioinformatics (1) Biology of Malignant Lymphomas (9) Genetics and Genomics of Cardiovascular Diseases (1) (-) Molecular Cell Biology and Gene Therapy (4) Molecular Immunology and Gene Therapy (18) Molecular Immunotherapy (3) Proteome Dynamics (1) Signal Transduction in Tumor Cells (1) Structural Biology of Membrane-Associated Processes (1) 4 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Molecular Cell Biology and Gene Therapy201020112019 Sort: Result score Newest to oldest Oldest to newest January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein January 15, 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens April 15, 2010 in Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
January 02, 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
July 28, 2011 in Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
January 15, 2011 in Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
April 15, 2010 in Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
